Clinical Trials Browser

Terminated × Urinary Bladder Neoplasms × Lapatinib × Clear all

NCT01245660 2013-01-11

LAPAINBLAD

Phase EARLY_PHASE1 Terminated

Urinary Bladder Neoplasms

NCT00447226 2012-06-12

Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists

Phase 2 Terminated

32 enrolled 10 charts

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms